Morgan Eileen, Arnold Melina, Camargo M Constanza, Gini Andrea, Kunzmann Andrew T, Matsuda Tomohiro, Meheus Filip, Verhoeven Rob H A, Vignat Jérôme, Laversanne Mathieu, Ferlay Jacques, Soerjomataram Isabelle
Cancer Surveillance Branch, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France.
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
EClinicalMedicine. 2022 Apr 21;47:101404. doi: 10.1016/j.eclinm.2022.101404. eCollection 2022 May.
To examine global patterns of gastric cancer in 2020 and the projected burden in 2040.
Data on primary gastric cancer were extracted from the GLOBOCAN database for the year 2020. Age-standardized incidence and mortality rates were calculated by sex, country, world region and level of human development index (HDI) for 185 countries. The predicted burden of incidence and mortality in 2040 was calculated based on demographic projections.
In total, ∼1.1 million new cases and 770,000 deaths of gastric cancer were estimated in 2020. Incidence rates were on average 2-fold higher in males than females (15.8 and 7.0 per 100,000, respectively) with variation across countries. Highest incidence rates were observed in Eastern Asia for both males and females (32.5 and 13.2, respectively); males residing in Japan (48.1), Mongolia (47.2) and Korea (39.7) had the highest rates in the world. Incidence was lowest in Africa with incidence rates < 5 per 100,000. Highest mortality rates were observed in Eastern Asia for both males (21.1) and females (8.8). A lower share of deaths was observed in very high HDI countries compared to medium and low HDI countries. The annual burden of gastric cancer is predicted to increase to ∼1.8 million new cases and ∼1.3 million deaths by 2040.
These estimates of the global burden of gastric cancer pinpoint countries and regions of high incidence and mortality in need of cancer control initiatives. Primary prevention through eradication of and behavioural changes such as reducing salt intake, smoking, obesity, and alcohol, remains key in stomach cancer control.
No direct funding was received. All authors had access to the included study data and all authors agreed with the final decision to submit for publication.
研究2020年全球胃癌模式及2040年预计负担情况。
从全球癌症数据库(GLOBOCAN)提取2020年原发性胃癌数据。计算了185个国家按性别、国家、世界区域和人类发展指数(HDI)水平划分的年龄标准化发病率和死亡率。基于人口预测计算了2040年预计发病率和死亡率负担。
2020年估计总计有近110万例胃癌新发病例和77万例死亡。男性发病率平均是女性的2倍(分别为每10万人15.8例和7.0例),各国存在差异。东亚地区男性和女性发病率均最高(分别为32.5和13.2);居住在日本(48.1)、蒙古(47.2)和韩国(39.7)的男性发病率为全球最高。非洲发病率最低,每10万人发病率<5例。东亚地区男性(21.1)和女性(8.8)死亡率最高。与中、低人类发展指数国家相比,人类发展指数非常高的国家死亡比例较低。预计到2040年,胃癌年度负担将增至近180万例新发病例和约130万例死亡。
这些全球胃癌负担估计数确定了需要开展癌症控制举措的高发病率和高死亡率国家及地区。通过根除幽门螺杆菌以及减少盐摄入、吸烟、肥胖和饮酒等行为改变进行一级预防,仍是胃癌控制的关键。
未接受直接资金。所有作者均可获取纳入研究数据,所有作者均同意提交发表的最终决定。